|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,950.00 GBX | -0.41% |
|
+2.44% | +6.88% |
| 06-16 | GSK's Exdensur Wins Canadian Approval for Severe Asthma, Nasal Polyps | MT |
| 06-16 | Saudi Chemical Co. Secures New Medical Marketing Services Deal from GSK Unit | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.41% | +2.44% | +4.70% | -3.75% | +6.88% | +31.27% | +42.90% | +8.67% | +11.51% | 105B | |
| -0.61% | -1.94% | +11.70% | +13.48% | +4.45% | +39.00% | +150.72% | +408.47% | +1,411.78% | 1,007B | |
| -0.20% | -0.77% | +3.74% | -3.29% | +13.64% | +51.51% | +43.20% | +43.03% | +101.63% | 567B | |
| +0.40% | -1.31% | +5.74% | +0.46% | -2.63% | +16.56% | +60.47% | +92.56% | +265.30% | 392B | |
| -1.18% | +2.29% | +1.02% | +1.18% | -0.64% | +24.04% | +16.53% | -6.05% | +36.44% | 328B | |
| -0.43% | +1.12% | +2.59% | -1.43% | +9.22% | +24.21% | +31.89% | +40.53% | +62.53% | 277B | |
| +0.64% | -2.55% | -2.55% | -7.52% | -3.67% | +22.80% | +12.69% | +58.07% | +248.57% | 275B | |
| -1.86% | +4.01% | -6.32% | +12.89% | -13.82% | -43.73% | -49.21% | +7.99% | +65.66% | 196B | |
| -0.77% | +0.95% | +6.60% | -5.03% | +6.27% | +17.69% | +51.46% | +45.19% | +128.39% | 189B | |
| +2.36% | +1.38% | -1.81% | -12.38% | +3.66% | +14.80% | +61.34% | +88.96% | +52.35% | 154B | |
| +0.15% | +1.32% | +2.80% | -2.14% | +4.58% | +6.72% | -35.00% | -33.74% | -25.06% | 148B | |
| -0.57% | -0.99% | -1.89% | -6.35% | +3.67% | +14.92% | -15.48% | -16.44% | -22.04% | 115B | |
| +0.60% | +1.66% | +3.71% | -2.77% | -0.04% | +0.50% | +30.26% | +141.70% | +401.24% | 114B | |
| +0.16% | -1.79% | +2.30% | -1.11% | -8.53% | -11.90% | -20.91% | -14.96% | +11.64% | 105B | |
| +1.38% | +0.83% | -3.32% | -18.19% | -7.52% | +3.24% | +79.92% | +75.40% | +541.49% | 76.33B | |
| -1.27% | -2.21% | -5.54% | -14.81% | +2.54% | +14.11% | +6.97% | +31.97% | +14.85% | 50.19B | |
| -1.11% | +2.09% | -12.30% | -14.82% | -20.51% | -11.92% | -0.32% | -33.13% | +228.04% | 46.79B | |
| -0.83% | +1.47% | -4.51% | -10.18% | -2.70% | +30.59% | -31.19% | -32.39% | -58.97% | 41.39B | |
| -2.32% | -4.47% | -4.02% | +11.71% | +5.45% | +88.06% | +336.47% | +211.35% | -36.97% | 39.23B | |
| -0.54% | -0.66% | +0.12% | -13.59% | -11.07% | -14.76% | +2.32% | - | - | 39.9B | |
| Average | -0.33% | +0.27% | +0.14% | -3.88% | -0.54% | +15.88% | +38.75% | +58.80% | +180.97% | 213.37B | |
| Weighted average by Cap. | -0.29% | -0.13% | +3.78% | +1.00% | +2.52% | +23.95% | +57.29% | +128.33% | +429.84% |
- Stock Market
- Stocks
- GSK Stock
- Sector GSK plc
Select your edition
All financial news and data tailored to specific country editions
